-
Boehringer forms new alliance to develop gene therapy
pharmaceutical-technology
August 08, 2018
Boehringer Ingelheim has entered a global partnership with the UK Cystic Fibrosis Gene Therapy Consortium (GTC), Imperial Innovations and Oxford BioMedica (OXB) to develop a new long-term gene therapy for cystic fibrosis (CF).
-
Akouos raises $50M to take hearing loss gene therapy into humans
fiercebiotech
August 08, 2018
Akouos has raised $50 million to take a gene therapy treatment for hearing loss into the clinic. The Boston-based biotech unveiled the series A round alongside the appointment of a Spark Therapeutics co-founder and other organizational changes.
-
Quality blip halts Sarepta muscular dystrophy gene therapy trial
fiercebiotech
July 30, 2018
A phase 1/2a trial Sarepta’s gene therapy for Duchenne muscular dystrophy (DMD) has been placed on clinical hold by the FDA after rogue DNA was found in a test sample.
-
PTC inks $200M Agilis takeover to snag late-phase gene therapy
fiercebiotech
July 26, 2018
PTC Therapeutics is paying $200 million upfront to acquire Agilis Biotherapeutics. The deal gives PTC ownership of a gene therapy treatment for rare neurotransmitter disease AADC deficiency that is set to go before the FDA next year.
-
Amryt in-licenses novel gene therapy platform from UCD
pharmatimes
July 23, 2018
UK biotech Amryt has secured itself access to a novel gene therapy platform that could give rise to a new treatment option for patients with Epidermolysis bullosa (EB), a group of rare inherited skin disorders that cause the skin to become very fragile.
-
Novartis snaps up AveXis in $8.7bn deal
pharmatimes
July 17, 2018
Novartis is buying US gene therapy group AveXis in a deal valued at $8.7 billion.
-
Controlling CRISPR and gene therapy with an amino acid switch
fiercebiotech
July 09, 2018
Gene editing and gene therapy have a range of potential applications, from editing out disease-causing mutations to treating spinal cord injuries.
-
Plasticell leads gene therapy manufacturing consortium
biospectrumasia
June 27, 2018
UK’s innovation agency provides funding to develop advanced technologies for the manufacturing of autologous ex vivo gene therapies.
-
Axovant pivots with new gene therapy, Spark co-founder as CTO
fiercebiotech
June 11, 2018
After a disastrous year in which its Alzheimer’s attempts blew up and the once biotech star David Hung jumped ship, Axovant is continuing its change-up with a new focus and a new executive.
-
Gene therapy startup MeiraGTx files for $86M IPO
fiercebiotech
May 16, 2018
MeiraGTx has filed for an $86 million IPO to advance a handful of gene therapies into and through clinical trials.